Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 29 citing Hovind: Smoking and progression of diabetic nephropathy in type 1 diabetes. (0.10 sec) 

Diabetic nephropathy: diagnosis, prevention, and treatment

- diabetesjournals.org
JL Gross, MJ de Azevedo, SP Silveiro, LH Canani, … - Diabetes Care, 2005 - Am Diabetes Assoc
Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement
therapy and affects ∼40% of type 1 and type 2 diabetic patients. It increases the risk of
death, mainly from cardiovascular causes, and is defined by increased urinary albumin ...
Cited by 218 - Related articles - All 18 versions

Factors associated with progression to macroalbuminuria in microalbuminuric Type …


F Giorgino, L Laviola, P Cavallo Perin, B Solnica, J … - Diabetologia, 2004 - Springer
Aims/hypothesis. Type 1 diabetic patients who develop microalbuminuria are clearly disadvantaged
in terms of their risk of morbidity and mortality from renal and cardiovascular diseases. It is therefore
important to identify potential factors that can predict progression to macroalbuminuria. ...
Cited by 55 - Related articles - BL Direct - All 5 versions

Remission to normoalbuminuria during multifactorial treatment preserves kidney …


P Gaede, L Tarnow, P Vedel, HH Parving, O … - Nephrology Dialysis …, 2004 - ERA-EDTA
Results. During follow-up, 46 patients achieved remission to normoalbuminuria, 58 remained
microalbuminuric and 47 patients progressed to overt nephropathy. The mean (± SE) yearly
decline in GFR was lowest (2.3±0.4 ml/min/year) in patients who obtained remission, in ...
Cited by 44 - Related articles - BL Direct - All 6 versions

Changes in renal function after clinical islet transplantation: four-year observational …


PA Senior, M Zeman, BW Paty, EA Ryan, … - American Journal of …, 2007 - interscience.wiley.com
Tight glycemic control can reduce progression of diabetic nephropathy (DN) while the histological
changes may regress after pancreas transplantation. Clinical islet transplantation (CIT) can restore
euglycemia but the effects of CIT and concomitant immunosuppression on renal function ...
Cited by 44 - Related articles - BL Direct - All 5 versions

Effects of smoking on renal function in patients with type 1 and type 2 diabetes …

- oxfordjournals.org
SR Orth, T Schroeder, E Ritz, P Ferrari - Nephrology Dialysis …, 2005 - ERA-EDTA
Methods. We followed 185 patients with type 1 or 2 diabetes mellitus and with or without signs
of overt renal disease for at least 3 years, median 5.1 (3–6.8) years. Each patient had a baseline
visit and at least four follow-up visits (average 4.8±0.3). Cases were patients who were ...
Cited by 33 - Related articles - BL Direct - All 7 versions

Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults With Type 1 …


K Raile, A Galler, S Hofer, A Herbst, D Dunstheimer … - Diabetes Care, 2007 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A total of 27,805 patients from the nationwide, prospective
German Diabetes Documentation System survey were included in the present analysis. Inclusion
criteria were at least two documented urine analyses with identical classification. Urine ...
Cited by 25 - Related articles - BL Direct - All 5 versions

Prediction, progression and prevention of diabetic nephropathy. The Minkowski …

- peoriaendocrine.com [PDF] 
P Rossing - Diabetologia, 2006 - Springer
Abstract Diabetic nephropathy is a major problem for patients and health care systems. The costs
of treatment remain high. To confront the ongoing challenge, we need to identify individuals at
high risk for initiation and progres- sion of this devastating complication. Risk factors ...
Cited by 12 - Related articles - BL Direct - All 5 versions

Nutrition therapy for diabetic nephropathy


MJ Franz, ML Wheeler - Current Diabetes Reports, 2003 - Springer
Introduction The role of medical nutrition therapy in diabetic nephrop- athy remains
controversial. It is indisputable that optimiz- ing glycemic control, controlling blood pressure with
an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker ( ...
Cited by 10 - Related articles - BL Direct - All 2 versions

Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes …


T Skrivarhaug, HJ Bangstad, LC Stene, L … - Pediatric …, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 7 - Related articles - BL Direct - All 3 versions

Emerging drugs for diabetic nephropathy


S Bruno, D Cattaneo, N Perico, G … - Expert Opin. Emerging …, 2005 - Informa Pharma Science
There is an increasing number of patients with diabetes mellitus in many coun- tries. Diabetic
kidney disease, one of its microvascular complications, is also increasing markedly and has
become a major cause of end stage renal disease worldwide. Intervention for preventing ...
Cited by 6 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google